Tonix Pharma (TNXP) Company Sales Revenue

tonixpharma.com - graphic logo of issuer TNXP

Tonix Pharmaceuticals (TNXP) is optimizing expenses by outsourcing production and testing to third-party contractors. The company's total sales revenue on the GURU.Markets terminal line chart reflects a trend where the indicator has leveled off at 0.04. Despite promising developments in vaccines and CNS, a critical liquidity shortage and a lack of profitability create serious risks for the business's continued survival.

TNXP: Tonix Pharmaceuticals Holding Corp. Company Revenue 07/04/2022 - 11/17/2026

Comprehensive metric breakdowns and analytics for Tonix Pharmaceuticals Holding (TNXP)

- market price and analyst price targets:
Product sample of Tonix Pharmaceuticals Inc.

Tonix Pharmaceuticals sales measure the volume of products sold, reflecting the fundamental stability of the business model through daily market valuations. By analyzing the company's sales time series, an investor can detect early signs of shifting demand prior to the publication of financial statements. This indicator discounts the efficiency of commercial activities in real time. For Tonix Pharmaceuticals (TNXP), the current metric is limited by the R&D stage and high laboratory costs. Future revenue growth depends directly on the successful market launch of patented molecules.

Competing companies

HLN: Company Sales Revenue|Company Revenue Kenvue (KVUE)|VRNA (Verona Pharma Corp) - Company Sales Revenue|Company Revenue Jyong Biotech MENS|Ligand Pharma - Company Revenue|AMRX - Company Revenue|Company Total Revenue perrigo.com|ALVO (Alvotech SA) - Company Sales|Company Total Sales Volume Liquidia Technologies LQDA|GLPG (Galapagos N.V.) - Revenue and Sales Volume|ANIP: Company Sales Revenue|Company Revenue Afrezza (MNKD)|Revenue and Sales Volume amphastar.com (AMPH)|Revenue and Sales Volume PCRX (pacira.com)|Company Sales Revenue SPRY|Theravance Biopharma Inc - Revenue and Sales Volume|Company Gross Revenue Aquestive Therapeutics AQST|SCPH: Revenue and Sales Volume|Company Sales Tectonic Therapeutic, Inc.|Company Sales SXTC|EPRX: Company Sales Revenue|Company Sales BHST (BioHarvest Sciences Inc.)|Company Gross Revenue Invizyne|Company Revenue Oramed Pharmaceuticals ORMP|Company Sales Revenue ENTX|HYFT - Company Revenue|Company Sales Revenue ABVC (ABVC BioPharma Inc.)|CPIX: Revenue and Sales Volume|Quantum BioPharma Limited - Company Sales Revenue|FGEN (FibroGen Corp) - Revenue and Sales Volume|Revenue and Sales Volume Telomir Pharmaceuticals|Revenue and Sales Volume RANI|SNYR (Synergy CHC Corp.) - Company Sales Revenue|Revenue and Sales Volume RLYB (Rallybio Corp)|LEXX: Company Sales Volume|PULM - Company Revenue|PTHL: Company Revenue|APM (aptorumgroup.com) - Company Sales|Lyra Therapeutics - Company Sales Revenue|Company Revenue Impact BioMedical Inc|TNF Pharmaceuticals, Inc. (TNFA) - Company Gross Revenue|Revenue and Sales Volume YCBD|PRFX: Company Annual Revenue|Company Revenue altamiratherapeutics.com CYTO|Revenue and Sales Volume Lipella Pharmaceuticals Inc LIPO|OPTN - Company Revenue|Company Gross Revenue Pieris Pharma PIRS|Procaps Group SA (PROC) - Company Revenue|Company Annual Revenue PTPI (Petros Pharmaceuticals, Inc.)|QLI (Qilian International Holding) - Revenue and Sales Volume|SLRN: Company Sales Revenue|Revenue and Sales Volume TFFP